Clinical Trials Information Disclosure

This site provides details on our corporate clinical trial disclosure policy and commitments and access to information on clinical trial protocols, study results, and plain (lay) language study results summaries.

Our Disclosure Commitments

Daiichi Sankyo is committed to the appropriate disclosure of information from its clinical trials. We believe that making protocols information and clinical trial data available to researchers, health care professionals, patients, academicians and others, in appropriate formats, advances science and medicine. These interactions hold promise for the improvement of public health, increased knowledge and deeper trust in pharmaceutical medicines.

As such, Daiichi Sankyo discloses information from our clinical trials through registration and postings on widely accepted public clinical trial registries, in line with our corporate commitments as well as international and national regulatory requirements and disclosure norms established by global and regional pharmaceutical industry associations.

Clinical Trials Information

Phase I to IV clinical trials are disclosed in Clinical Trial Registries accessible to the public free of charge in line with applicable regulations. Each registry contains adequate trial information to inform prospective clinical trial volunteers, health care practitioners and the general public of the clinical trial title, design, identification / registration number, description and purpose, medical condition or disease being studied, key eligibility criteria, recruitment status, trial sites and contact for information on enrollment.

Clinical Trials and Study Results

Clinical Trial Data Sharing

In addition to routinely publishing clinical research in scientific journals and collaborating with academic researchers, Daiichi Sankyo also complies with applicable regulations and the principles set forth by the European Federation of Pharmaceutical Industries Association (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) to responsibly share clinical trial data upon formal request and approval by an independent review panel.

Patient-level Clinical Trial Data for Researchers

Links to Clinical Trial Registries and Data Sharing Portal